Navigation Links
Vaginalis Increases the Risk of Becoming Infected With HIV

Infection with Trichomonas vaginalis significantly increases a woman’s risk of becoming infected with HIV, according to a study// published in the March 1st edition of The Journal of Infectious Diseases (now online).

It is now well established that several sexually transmitted infections increase the risk of transmission and acquisition of HIV. Although there are 173 million cases of Trichomonas vaginalis per year worldwide, there are few robust data regarding the association of the infection with the risk of HIV acquisition.

A team of investigators from the university of Washington in the United States and Mombasa in Kenya hypothesised that infection with Trichomonas vaginalis increased the risk of HIV acquisition in women and therefore conducted an eleven-year prospective study involving sex workers in Mombasa.

The study ran between 1993 and 2004 and involved 1,335 female sex workers who were HIV-negative at baseline. At monthly intervals, the women provided information about their general medical, gynaecological and sexual health. The women also had physical examinations and were screened for HIV and a variety of sexually transmitted infections, including Trichomonas vaginalis.

The association between Trichomonas vaginalis and HIV acquisition was tested using both univariate and multivariate analysis. The multivariate model controlled for education, alcohol use, workplace (bar versus night-club), vaginal washing practices, genital tract infections other than Trichomonas vaginalis, type of contraceptive used, age, number of sex partners per week, frequency of sex per week, and condom use (100% versus under 100%).

A total of 3,422 person-years of follow-up were available for the investigators’ analysis. There were a total of 806 incident infections with Trichomonas vaginalis (23.6 per 100 person years), and 265 women became infected with HIV (7.7/100 person years).

In univariate analysis, infection wit
'"/>




Page: 1 2 3

Related medicine news :

1. Step Aerobics Increases good cholesterol
2. Gene Increases Cancer Risk
3. Obesity Increases Risk of Cervical Cancer
4. Psoriasis Increases Cancer Risk
5. Treatment For Prostate Cancer Found To Increases Fracture Risk
6. Risk for Cancer Increases In Diabetics
7. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
8. Smoking Increases The Risk Of Developing Tuberculosis Infection
9. Choice Of Treatment Increases Risk Of Death In Kidney Disease
10. Air Pollution Increases Risk For Heart Disease In Women
11. A Protein That Increases Risk Of Tumours
Post Your Comments:
Other Medicine News:Health News:Operation Rescue Launches Opposition to Gov. Sebelius' Confirmation as HHS Secretary 2Health News:Operation Rescue Launches Opposition to Gov. Sebelius' Confirmation as HHS Secretary 3Health News:Latinos Manage Diabetes With Help From the Community 2Health News:Latinos Manage Diabetes With Help From the Community 3Health News:AIDS care physicians make recommendations to Obama 2Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 2Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 3Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 4Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 5Health News:New Jersey to Launch New Statewide Effort to Promote Childhood Obesity Prevention 2Health News:New Jersey to Launch New Statewide Effort to Promote Childhood Obesity Prevention 3Health News:New Jersey to Launch New Statewide Effort to Promote Childhood Obesity Prevention 4Health News:Kathleen Sebelius Ready to Lead Healthcare Reform in 2009 2
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Exponent Reports Second Quarter 2009 Results 52462 1Exponent Reports Second Quarter 2009 Results 52462 2Exponent Reports Second Quarter 2009 Results 52462 3Exponent Reports Second Quarter 2009 Results 52462 4Exponent Reports Second Quarter 2009 Results 52462 5Exponent Reports Second Quarter 2009 Results 52462 6Exponent Reports Second Quarter 2009 Results 52462 7Exponent Reports Second Quarter 2009 Results 52462 8Exponent Reports Second Quarter 2009 Results 52462 9Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 1Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 2Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 3Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 4Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 5Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 1Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 2Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 3Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 4Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 5Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 6Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 7Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 8Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 9Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 10Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 11Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 12Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 13Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 14Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 15Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 16Pelosi Remarks at Press Conference Today on Health Care Reform and Medical Costs 52458 17